The vital role of the primary care team: Highlights from the AHA Scientific Statement on CKM Syndrome

The primary care team is often the first to evaluate and assess chronic conditions and interconnected comorbidities, such as steatotic liver disease, renal disease and Type 2 diabetes (T2D), using diagnostic assays. The early detection, progression assessment and effective management of cardiovascular-kidney-metabolic (CKM) conditions is critical for optimal patient outcomes.

Here, we discuss the unique positioning of the primary care team in light of the American Heart Association’s scientific statement formally defining cardiovascular-kidney-metabolic syndrome and providing recommendations for the clinical management of patients.¹

References

1. Ndumele CE, Neeland IJ, Tuttle, KR, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement from the American Heart Association. Circulation. 2023; 148(20):1636-1664